From a clinical perspective, it is well‐known that enhancement of insulin sensitivity, rather than plasma glucose level, has a major role in improving diabetes outcomes, while insulin resistance is a better predictor of future cardiovascular events in nondiabetic individuals.99 The gene discussed is INS; the disease is Insulin resistance.